Our findings indicate that lymphoma patients capable of mounting T cell responses compensate for impaired B cell activity by producing antigen-specific CD8 + T cells comparable to HC but, through elevated CD8 + EMRA cells. This evidence concerns the gene CD8A and lymphoma.